SpringWorks Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

SpringWorks Therapeutics

20/02/2025 14:32

* SpringWorks Therapeutics Inc  SWTX.OQ  reported a
quarterly
adjusted loss of $1.04​​ per share for the quarter ended
December 31, higher than the same quarter last year, when the
company reported EPS of $-1.45.  The mean expectation of
seven analysts for the quarter was for a loss of 70 cents per
share. Wall Street expected results to range from -73 cents
to -65 cents per share.
    * Revenue was $61.55 million​; analysts expected $59.12
million. 
    * SpringWorks Therapeutics Inc's reported EPS for the
quarter was
a loss of $1.04​.
    * The company reported a quarterly loss of $77.3 million.
    * SpringWorks Therapeutics Inc shares had risen by 54.2%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 8.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for SpringWorks
Therapeutics Inc is $70.00 
This summary was machine generated from LSEG data February 20 at
02:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.70          -1.04          Missed
 Sep. 30 2024      -0.75          -0.72          Beat
 Jun. 30 2024      -1.11          -0.54          Beat
 Mar. 31 2024      -1.17          -1.18          Missed